tiprankstipranks
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
PremiumPress ReleasesRxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
2M ago
RxSight price target raised to $64 from $54 at Stifel
PremiumThe Fly
RxSight price target raised to $64 from $54 at Stifel
2M ago
RxSight price target raised to $64 from $53 at Needham
PremiumThe Fly
RxSight price target raised to $64 from $53 at Needham
2M ago
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 
PremiumPress ReleasesRxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 
2M ago
RxSight price target raised to $54 from $45 at Stifel
PremiumThe Fly
RxSight price target raised to $54 from $45 at Stifel
2M ago
RxSight price target raised to $41 from $35 at Needham
PremiumThe Fly
RxSight price target raised to $41 from $35 at Needham
4M ago
RxSight reports preliminary unaudited Q4 revenue $28.6M, consensus $25.76M
PremiumThe FlyRxSight reports preliminary unaudited Q4 revenue $28.6M, consensus $25.76M
4M ago
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
PremiumPress Releases
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
4M ago
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
PremiumPress Releases
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100